LumiraDx Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LMDX research report →
About the company
LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care.
- CEO
- Veronique Ameye EMBA,
- IPO
- 2021
- Employees
- 1,210
- HQ
- London, GB
Price Chart
- Market Cap
- $5.10M
- P/E
- -0.01
- P/S
- 0.02
- P/B
- -0.04
- EV/EBITDA
- -1.12
- Div Yield
- 0.00%
- Gross Margin
- -13.87%
- Op Margin
- -126.32%
- Net Margin
- -176.52%
- ROE
- -1557.76%
- ROIC
- -89.68%
- Revenue
- $254.48M · -39.62%
- Net Income
- $-449,195,000 · -345.79%
- EPS
- $-1.59 · -297.50%
- Op Income
- $-321,447,000
- FCF YoY
- 22.44%
- 52W High
- $0.03
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- 1.71
- Avg Volume
- 120.55M
Get TickerSpark's AI analysis on LMDX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LMDX coverage
Recent articles, reports, and earnings notes.
No research on LMDX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LMDX report →Similar companies
Peers in the same neighborhood.